4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-23-001175
CHIEF EXECUTIVE OFFICER bought 20,000 shares at $3.98 ($79,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2023-02-27 | Purchase | +20,000 | $3.98 | $79,600 | 6,011,873 | D |
| Open-market purchases · 20,000 sh · avg $3.98 · $79,600 | |||||||
Loading xslF345X03/ownership.xml…